UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents

Leukemia, 2012-01, Vol.26 (1), p.73-85

2012

Volltextzugriff (PDF)

Inhibition of FLT3 in AML: a focus on sorafenib

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.344-351

2017

Volltextzugriff (PDF)

Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.1074-1077

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Leukemia, 2016-10, Vol.30 (10), p.2047-2054

2016

Volltextzugriff (PDF)

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Bone marrow transplantation (Basingstoke), 2017-06, Vol.52 (6), p.918-921

2017

Volltextzugriff (PDF)

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients

Clinical microbiology and infection, 2014-02, Vol.20 (2), p.160-166

2014

Volltextzugriff (PDF)

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.639-645

2012

Volltextzugriff (PDF)

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

Bone marrow transplantation (Basingstoke), 2016-03, Vol.51 (3), p.462-465

2016

Volltextzugriff (PDF)

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1475-1480

2014

Volltextzugriff (PDF)

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.349-353

2010

Volltextzugriff (PDF)

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1395-1400

2013

Volltextzugriff (PDF)

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.592-599

2017

Volltextzugriff (PDF)

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1134-1136

2016

Volltextzugriff (PDF)

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.194-198

2016

Volltextzugriff (PDF)

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1000-1005

2011

Volltextzugriff (PDF)

Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning

Leukemia, 2013-11, Vol.27 (11), p.2113-2117

2013

Volltextzugriff (PDF)

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.794-798

2013

Volltextzugriff (PDF)

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.249-252

2013

Volltextzugriff (PDF)

Rituximab as salvage therapy for refractory chronic GVHD

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.909-911

2008

Volltextzugriff (PDF)

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

Leukemia, 2009-01, Vol.23 (1), p.194-196

2009

Volltextzugriff (PDF)

TLI in refractory chronic GVHD

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.854-858

2013

Volltextzugriff (PDF)

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1552

2014

Volltextzugriff (PDF)

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis

Bone marrow transplantation (Basingstoke), 2011-02, Vol.46 (2), p.317-318

2011

Volltextzugriff (PDF)

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations

Haematologica (Roma), 2010-02, Vol.95 (2), p.311-319

2010

Volltextzugriff (PDF)

Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation

Current research in translational medicine, 2019-08, Vol.67 (3), p.93-99

2019

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(228)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents

Inhibition of FLT3 in AML: a focus on sorafenib

Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

Rituximab as salvage therapy for refractory chronic GVHD

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

TLI in refractory chronic GVHD

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations

Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation

Suchergebnisse filtern